Appointed
Ramona A. Sequeira
Director
OGN ·
Organon & Co.
the appointment of Ramona A. Sequeira will become immediately effective to fill the resulting vacancy.
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6501–6550 of 75459
the appointment of Ramona A. Sequeira will become immediately effective to fill the resulting vacancy.
unanimously elected Paul Shalhoub and Gilbert Nathan to serve as new directors, effective immediately.
unanimously elected Paul Shalhoub and Gilbert Nathan to serve as new directors, effective immediately.
appointed Stephen Kadenacy, the Company’s current Chief Financial Officer, and Sean Moriarty to fill the vacancies created by such increase in the size of the Board.
appointed Stephen Kadenacy, the Company’s current Chief Financial Officer, and Sean Moriarty to fill the vacancies created by such increase in the size of the Board.
On April 11, 2025, Nathan Tewalt was appointed to the Board of Directors (the "Board") of enCore Energy Corp. (the "Company") with a term set to expire at the 2025 annual general meeting of shareholders.
Scott Armstrong provided notice of his intent to retire from the Boards and as a member of the applicable Board committees on which he serves, effective September 30, 2025.
the Boards of Directors (the “Boards”) of Puget Energy, Inc. and Puget Sound Energy, Inc. (together, the “Companies”) appointed Bertrand (Bert) A. Valdman as a director of the Companies.
Effective April 9, 2025, the board of directors (the “Board”) of Identiv, Inc. (the “Company” or “Identiv”) appointed Miguel (“Mick”) A. Lopez to serve as a member of the Board.
On April 9, 2025, Graig Springer informed Hoth Therapeutics, Inc. (the “Company”) that he will be resigning from the Company’s Board of Directors (the “Board”) as well as the Company’s audit committee, compensation committee and nominating and corporate governance committee effective as of April 15, 2025.
In the interim, the Company’s Chief Financial Officer, Kristin Schultes, will assume the responsibility of Principal Accounting Officer.
As of April 11, 2025, Acuren Corporation (the “Company”) announced the departure of Gregory Conaway, the Company’s Chief Accounting Officer.
Mr. Onorati succeeds Blake Janover, who previously served as Chief Executive Officer.
effective April 4, 2025, Parker White was appointed as the Chief Operating Officer and Chief Investment Officer of the Company.
effective April 4, 2025, Joseph Onorati was appointed as the Chief Executive Officer of Janover Inc.
On April 14, 2025, Green Plains Inc. appointed three individuals as independent members of its board of directors, including Steven Furcich, Carl Grassi, and Patrick Sweeney.
On April 14, 2025, Green Plains Inc. appointed three individuals as independent members of its board of directors, including Steven Furcich, Carl Grassi, and Patrick Sweeney.
On April 14, 2025, Green Plains Inc. appointed three individuals as independent members of its board of directors, including Steven Furcich, Carl Grassi, and Patrick Sweeney.
on April 1, 2025, Scott Recknor, the Company’s Head of Asset Management, notified the Company of his decision to retire.
On April 15, 2025, Under Armour, Inc. (the “Company” or “Under Armour”) issued a press release announcing the election of Dawn N. Fitzpatrick, age 55, Eugene D. Smith, age 69, and Robert J. Sweeney, age 57, as Directors of the Company effective April 15, 2025.
On April 15, 2025, Under Armour, Inc. (the “Company” or “Under Armour”) issued a press release announcing the election of Dawn N. Fitzpatrick, age 55, Eugene D. Smith, age 69, and Robert J. Sweeney, age 57, as Directors of the Company effective April 15, 2025.
On April 15, 2025, Under Armour, Inc. (the “Company” or “Under Armour”) issued a press release announcing the election of Dawn N. Fitzpatrick, age 55, Eugene D. Smith, age 69, and Robert J. Sweeney, age 57, as Directors of the Company effective April 15, 2025.
On April 14, 2025, the Company’s Board of Directors (the “Board”) appointed Anthony W. Oxley, the Company’s President and Chief Executive Officer, to serve as a director on the Board.
Effective April 11, 2025, Charles Frischer. resigned as a director of Kingsway Financial Services Inc. (“Company”) and member of the Audit Committee.
On April 14, 2025, the Board appointed Ryan Schluttenhofer as Chief Accounting Officer, Treasurer and Secretary of the Company effective as of April 17, 2025.
On April 9, 2025, Michael A. Bender informed the board of directors (the “Board”) of Pacific Oak Strategic Opportunity REIT, Inc. (the “Company”) of his resignation from his position as Executive Vice President, Chief Financial Officer, Treasurer and Secretary of the Company effective as of April 17, 2025.
the Board appointed Sipho Maseko as director
Dr. Hendrik Strydom, PhD, Chief Technology Officer of the Company, stepped down as a member of the board of directors of the Company
the board of directors of the Company, accepted the resignation of Robert Holcomb.
Scott Recknor, the Company’s Head of Asset Management, notified the Company of his decision to retire.
Ken Myszkowski notified Arrowhead Pharmaceuticals, Inc. (the “Company”) of his decision to retire as Chief Financial Officer of the Company, effective as of May 13, 2025
the Company determined that it would appoint Daniel Apel to serve as Chief Financial Officer of the Company
On April 9, 2025, Hakan Kardes, Chief Experience Officer of Alignment Healthcare, Inc. (the “Company”), notified the Company of his intention to resign his employment with the Company to pursue other professional opportunities.
Renger van den Heuvel was appointed as the Chief Executive Officer of the Company and as a member of the Company’s Board of Directors.
Howard Gostfrand and Brian Klatsky resigned from their positions as officers of the Company
Laura Anthony resigned from her positions as a director and officer of the Company
Howard Gostfrand and Brian Klatsky resigned from their positions as officers of the Company
Renger van den Heuvel was appointed as the Chief Executive Officer of the Company and as a member of the Company’s Board of Directors.
Laura Anthony resigned from her positions as a director and officer of the Company
On April 14, 2025, the Company’s Board of Directors, pursuant to a Board resolution, established the size of the Board at 9 directors, and elected Meghan Pasricha, age 39, to serve as a Class III director until the 2025 Annual Meeting of Stockholders.
On April 15, 2025, Rhinebeck Bancorp, Inc. (the “Company”), its wholly-owned subsidiary, Rhinebeck Bank (the “Bank”), and its mutual holding company, Rhinebeck Bancorp, MHC (the “MHC”), announced that Sharon McGinnis and Nancy K. Patzwahl have been appointed to the Board of Directors of the Company, the Bank and the MHC, effective April 15, 2025.
On April 15, 2025, Rhinebeck Bancorp, Inc. (the “Company”), its wholly-owned subsidiary, Rhinebeck Bank (the “Bank”), and its mutual holding company, Rhinebeck Bancorp, MHC (the “MHC”), announced that Sharon McGinnis and Nancy K. Patzwahl have been appointed to the Board of Directors of the Company, the Bank and the MHC, effective April 15, 2025.
Also on April 14, 2025, the Company appointed Daniel J. Rice IV, the Company’s Chief Executive Officer, as President and Interim Chief Financial Officer and Marc Horstman as Chief Operating Officer.
Also on April 14, 2025, the Company appointed Daniel J. Rice IV, the Company’s Chief Executive Officer, as President and Interim Chief Financial Officer and Marc Horstman as Chief Operating Officer.
On April 14, 2025, it was determined that Brian Allen and Akash Patel will no longer serve as President and Chief Operating Officer and Chief Financial Officer, respectively, of Net Power Inc. (the “Company”), effective as of April 15, 2025.
On April 14, 2025, it was determined that Brian Allen and Akash Patel will no longer serve as President and Chief Operating Officer and Chief Financial Officer, respectively, of Net Power Inc. (the “Company”), effective as of April 15, 2025.
on April 15, 2025, the board of directors of the Company appointed Ellen Conti to serve as the Company’s Chief Financial Officer and Treasurer and as a member of its board of directors.
On April 11, 2025, Herbert Alvin (“Hap”) Pollard notified the Company of his resignation as Chief Financial Officer and Treasurer and as a member of the board of directors of Sculptor Diversified Real Estate Income Trust, Inc.
On March 7, 2025, West Pharmaceutical Services, Inc. (the “Company”) announced that Cindy Reiss-Clark, former Senior Vice President and Chief Commercial Officer, departed from the Company effective that same date.
On April 10, 2025 and effective as of that date, Fannie Mae’s Board of Directors appointed Mr. Stucky to serve as Vice Chair of the Board.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.